Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer.

Name: Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer.
Author: Denda, Tadamichi

Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer. — المؤلف: Denda, Tadamichi — Cancer science 20190308

المؤلف: Denda, Tadamichi
النشر: Cancer science 20190308
الوصف: 1032-1043 p.
الموضوعات: Aged؛ Antineoplastic Combined Chemotherapy Protocols؛ Asian People؛ Camptothecin؛ Colorectal Neoplasms؛ Disease-Free Survival؛ Fluorouracil؛ Humans